DERM—Two Phase 3 Trials Evaluating Olumacostat Glasaretil in Patients with Acne Vulgaris Did Not Meet Co-Primary Endpoints https://globenewswire.com/news-release/2018/03/05/1414799/0/en/Dermira-s-Two-Phase-3-Trials-Evaluating-Olumacostat-Glasaretil-in-Patients-with-Acne-Vulgaris-Did-Not-Meet-Co-Primary-Endpoints.html